Posted 2 months ago

A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1). (MEVPRO-1)

ClinicalTrials.gov ID NCT06551324

Protocol number C2321014

Sponsor Pfizer